Emfilermin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Emfilermin, covering 2017-01-04 to 2017-01-04. Get the full timeline:
Most recent: Clinical Trial Update: A Multicentre, Randomised, Double-blind, Placebo-controlled Proof of Concept Study to Compare the Efficacy and Safety of r-hLIF (Emfilermin) for Improving Embryo Implantation Following in Vitro Fertilization (IVF) and Embryo Transfer (ET) in Women With Recurrent Implantation Failure [Phase 1, Phase 2]